No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 2 genes, 3 drugs (DrugBank) and 39 diseases shown |
1件: KIT |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2 | Adherens junction 4 genes, 2 drugs (DrugBank) and 4 diseases shown |
1件: FGFR1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
3件: FYN, SRC, YES1 |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
3 | Adipocytokine signaling pathway 2 genes, 6 drugs (DrugBank) and 61 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
4 | Adrenergic signaling in cardiomyocytes 2 genes, 3 drugs (DrugBank) and 28 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
5 | African trypanosomiasis 4 genes, 5 drugs (DrugBank) and 41 diseases shown |
4件: IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
6 | AGE-RAGE signaling pathway in diabetic complications 10 genes, 8 drugs (DrugBank) and 55 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
5件: CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
7 | Aldosterone synthesis and secretion 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
8 | Allograft rejection 2 genes, 5 drugs (DrugBank) and 41 diseases shown |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
9 | Alzheimer disease 7 genes, 6 drugs (DrugBank) and 56 diseases shown |
2件: IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
10 | Amoebiasis 7 genes, 6 drugs (DrugBank) and 42 diseases shown |
4件: IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
11 | Amphetamine addiction 5 genes, 1 drug (DrugBank) and 30 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
12 | AMPK signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
13 | Amyotrophic lateral sclerosis (ALS) 6 genes, 6 drugs (DrugBank) and 56 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
14 | Antifolate resistance 3 genes, 5 drugs (DrugBank) and 41 diseases shown |
3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
15 | Antigen processing and presentation 1 gene, 5 drugs (DrugBank) and 41 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
16 | Apelin signaling pathway 3 genes, 3 drugs (DrugBank) and 45 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: CCN2 |
D10969 |
Pamrevlumab |
2件: 85, 113 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
17 | Apoptosis 1 gene, 5 drugs (DrugBank) and 41 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
18 | Arachidonic acid metabolism 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: ALOX5 |
D00414 |
Zileuton |
3件: 85, 160, 164 |
19 | Asthma 3 genes, 7 drugs (DrugBank) and 41 diseases shown |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL13 |
D09633 |
Lebrikizumab |
1件: 85 |
D09979 |
Tralokinumab |
2件: 85, 97 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
20 | Autoimmune thyroid disease 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: IL10 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
21 | Autophagy - animal 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
22 | Autophagy - other 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
23 | Axon guidance 10 genes, 4 drugs (DrugBank) and 36 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
4件: ABL1, EPHA2, FYN, SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SMO |
D09992 |
Vismodegib |
1件: 85 |
24 | B cell receptor signaling pathway 5 genes, 1 drug (DrugBank) and 30 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
25 | Bacterial invasion of epithelial cells 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
26 | Basal cell carcinoma 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: SMO |
D09992 |
Vismodegib |
1件: 85 |
27 | Bladder cancer 3 genes, 3 drugs (DrugBank) and 11 diseases shown |
1件: FGFR3 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
28 | Breast cancer 4 genes, 4 drugs (DrugBank) and 40 diseases shown |
2件: FGFR1, FLT4 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: KIT |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
29 | C-type lectin receptor signaling pathway 10 genes, 7 drugs (DrugBank) and 56 diseases shown |
4件: IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
30 | Calcium signaling pathway 13 genes, 13 drugs (DrugBank) and 55 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: CYSLTR1 |
D00529 |
Montelukast |
5件: 13, 46, 85, 98, 228 |
D08229 |
D06659 |
Tipelukast |
1件: 85 |
1件: EDNRA |
D07077 |
Ambrisentan |
6件: 51, 84, 85, 86, 88, 211 |
2件: EDNRA, EDNRB |
D01227 |
Bosentan |
10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
5件: 51, 85, 86, 88, 210 |
1件: P2RX3 |
D11349 |
Gefapixant |
2件: 85, 226 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
31 | cAMP signaling pathway 3 genes, 6 drugs (DrugBank) and 26 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
1件: EDNRA |
D07077 |
Ambrisentan |
6件: 51, 84, 85, 86, 88, 211 |
D01227 |
Bosentan |
10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
5件: 51, 85, 86, 88, 210 |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
32 | Cell adhesion molecules (CAMs) 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CD274 |
D10773 |
Atezolizumab |
1件: 85 |
33 | Cell cycle 4 genes, 3 drugs (DrugBank) and 13 diseases shown |
1件: ABL1 |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
34 | Cellular senescence 11 genes, 5 drugs (DrugBank) and 54 diseases shown |
2件: IL1A, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
35 | Central carbon metabolism in cancer 7 genes, 4 drugs (DrugBank) and 40 diseases shown |
5件: FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
2件: KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: KIT, PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
36 | cGMP-PKG signaling pathway 11 genes, 9 drugs (DrugBank) and 55 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: EDNRA |
D07077 |
Ambrisentan |
6件: 51, 84, 85, 86, 88, 211 |
2件: EDNRA, EDNRB |
D01227 |
Bosentan |
10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
5件: 51, 85, 86, 88, 210 |
1件: OPRD1 |
D00843 |
Nalbuphine |
1件: 85 |
D08246 |
1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
D08514 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
37 | Chagas disease (American trypanosomiasis) 10 genes, 7 drugs (DrugBank) and 46 diseases shown |
5件: CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
38 | Chemokine signaling pathway 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: CCL2 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
39 | Choline metabolism in cancer 3 genes, 4 drugs (DrugBank) and 40 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
40 | Cholinergic synapse 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: FYN |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
41 | Chronic myeloid leukemia 4 genes, 3 drugs (DrugBank) and 13 diseases shown |
1件: ABL1 |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
42 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank) and 15 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
43 | Colorectal cancer 4 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
44 | Complement and coagulation cascades 1 gene, 2 drugs (DrugBank) and 2 diseases shown |
1件: F2 |
D09707 |
Dabigatran |
2件: 85, 91 |
D06410 |
Thrombomodulin Alfa |
1件: 85 |
45 | Cortisol synthesis and secretion 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
46 | Cushing syndrome 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
47 | Cytokine-cytokine receptor interaction 14 genes, 10 drugs (DrugBank) and 56 diseases shown |
6件: CCL2, IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: IL13 |
D09633 |
Lebrikizumab |
1件: 85 |
D09979 |
Tralokinumab |
2件: 85, 97 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
48 | Cytosolic DNA-sensing pathway 2 genes, 2 drugs (DrugBank) and 13 diseases shown |
2件: IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
49 | Dilated cardiomyopathy (DCM) 4 genes, 6 drugs (DrugBank) and 42 diseases shown |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
50 | Dopaminergic synapse 3 genes, 1 drug (DrugBank) and 30 diseases shown |
3件: PPP3CA, PPP3CB, PPP3CC |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
51 | Drug metabolism - other enzymes 4 genes, 4 drugs (DrugBank) and 39 diseases shown |
2件: IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
1件: RRM1 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
52 | EGFR tyrosine kinase inhibitor resistance 9 genes, 7 drugs (DrugBank) and 45 diseases shown |
5件: FGFR2, FGFR3, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: PDGFRB, SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
53 | Endocrine resistance 2 genes, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
54 | Endocytosis 4 genes, 3 drugs (DrugBank) and 12 diseases shown |
3件: FGFR2, FGFR3, PDGFRA |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
55 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
56 | Epstein-Barr virus infection 2 genes, 5 drugs (DrugBank) and 41 diseases shown |
2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
57 | ErbB signaling pathway 3 genes, 3 drugs (DrugBank) and 39 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: ABL1, SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
58 | Estrogen signaling pathway 2 genes, 3 drugs (DrugBank) and 5 diseases shown |
1件: OPRM1 |
D00320 |
Fentanyl |
5件: 46, 70, 85, 215, 231 |
D01399 |
D00843 |
Nalbuphine |
1件: 85 |
D08246 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
59 | Fc epsilon RI signaling pathway 4 genes, 9 drugs (DrugBank) and 42 diseases shown |
1件: ALOX5 |
D00414 |
Zileuton |
3件: 85, 160, 164 |
1件: FYN |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: IL13 |
D09633 |
Lebrikizumab |
1件: 85 |
D09979 |
Tralokinumab |
2件: 85, 97 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
60 | Fluid shear stress and atherosclerosis 8 genes, 9 drugs (DrugBank) and 50 diseases shown |
4件: CCL2, IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: KDR |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
D01280 |
D08682 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
61 | Focal adhesion 8 genes, 4 drugs (DrugBank) and 15 diseases shown |
5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
3件: FYN, PDGFRB, SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
62 | FoxO signaling pathway 5 genes, 3 drugs (DrugBank) and 14 diseases shown |
2件: IL10, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
63 | GABAergic synapse 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
64 | Gap junction 12 genes, 4 drugs (DrugBank) and 12 diseases shown |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
2件: PDGFRB, SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00491 |
Paclitaxel |
2件: 46, 85 |
D05333 |
65 | Gastric acid secretion 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
66 | Gastric cancer 5 genes, 3 drugs (DrugBank) and 38 diseases shown |
1件: FGFR2 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
67 | Glioma 3 genes, 4 drugs (DrugBank) and 40 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
68 | Glucagon signaling pathway 5 genes, 1 drug (DrugBank) and 30 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
69 | Glutamatergic synapse 5 genes, 1 drug (DrugBank) and 30 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
70 | Glutathione metabolism 2 genes, 2 drugs (DrugBank) and 21 diseases shown |
1件: RRM1 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
71 | GnRH signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
72 | Graft-versus-host disease 4 genes, 5 drugs (DrugBank) and 41 diseases shown |
4件: IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
73 | Growth hormone synthesis, secretion and action 2 genes, 2 drugs (DrugBank) and 40 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
74 | Hedgehog signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: SMO |
D09992 |
Vismodegib |
1件: 85 |
75 | Hematopoietic cell lineage 7 genes, 9 drugs (DrugBank) and 70 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
4件: IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: KIT |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
1件: MS4A1 |
D02994 |
Rituximab |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
76 | Hepatitis B 6 genes, 7 drugs (DrugBank) and 42 diseases shown |
2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
77 | Hepatitis C 1 gene, 5 drugs (DrugBank) and 41 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
78 | Hepatocellular carcinoma 5 genes, 3 drugs (DrugBank) and 41 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
D01280 |
D08682 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
79 | Herpes simplex virus 1 infection 9 genes, 8 drugs (DrugBank) and 65 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
80 | HIF-1 signaling pathway 6 genes, 6 drugs (DrugBank) and 48 diseases shown |
1件: FLT1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
81 | Hippo signaling pathway 4 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: CCN2 |
D10969 |
Pamrevlumab |
2件: 85, 113 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
82 | Human cytomegalovirus infection 13 genes, 11 drugs (DrugBank) and 69 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
83 | Human immunodeficiency virus 1 infection 7 genes, 7 drugs (DrugBank) and 68 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
84 | Human papillomavirus infection 4 genes, 9 drugs (DrugBank) and 62 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
85 | Human T-cell leukemia virus 1 infection 12 genes, 8 drugs (DrugBank) and 57 diseases shown |
2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: LCK |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
86 | Hypertrophic cardiomyopathy (HCM) 5 genes, 6 drugs (DrugBank) and 42 diseases shown |
2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
87 | IL-17 signaling pathway 5 genes, 7 drugs (DrugBank) and 41 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL13 |
D09633 |
Lebrikizumab |
1件: 85 |
D09979 |
Tralokinumab |
2件: 85, 97 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
88 | Inflammatory bowel disease (IBD) 11 genes, 9 drugs (DrugBank) and 46 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL13 |
D09633 |
Lebrikizumab |
1件: 85 |
D09979 |
Tralokinumab |
2件: 85, 97 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
89 | Inflammatory mediator regulation of TRP channels 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: IL1B |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
90 | Influenza A 7 genes, 6 drugs (DrugBank) and 45 diseases shown |
5件: CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
91 | Insulin resistance 3 genes, 6 drugs (DrugBank) and 61 diseases shown |
2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
92 | Insulin signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
93 | Intestinal immune network for IgA production 3 genes, 3 drugs (DrugBank) and 14 diseases shown |
2件: IL10, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TGFB1 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
94 | JAK-STAT signaling pathway 9 genes, 10 drugs (DrugBank) and 60 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
2件: IL10, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL13 |
D09633 |
Lebrikizumab |
1件: 85 |
D09979 |
Tralokinumab |
2件: 85, 97 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
95 | Kaposi sarcoma-associated herpesvirus infection 10 genes, 7 drugs (DrugBank) and 57 diseases shown |
1件: IFNGR1 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
96 | Legionellosis 3 genes, 5 drugs (DrugBank) and 41 diseases shown |
3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
97 | Leishmaniasis 9 genes, 7 drugs (DrugBank) and 46 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
4件: IL10, IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
98 | Long-term potentiation 5 genes, 1 drug (DrugBank) and 30 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
99 | Longevity regulating pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
100 | Longevity regulating pathway - multiple species 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
101 | Malaria 8 genes, 6 drugs (DrugBank) and 42 diseases shown |
5件: CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
102 | MAPK signaling pathway 22 genes, 11 drugs (DrugBank) and 59 diseases shown |
3件: EPHA2, KIT, PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
103 | Measles 3 genes, 2 drugs (DrugBank) and 13 diseases shown |
3件: IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
104 | Melanogenesis 2 genes, 4 drugs (DrugBank) and 17 diseases shown |
1件: EDNRB |
D01227 |
Bosentan |
10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
5件: 51, 85, 86, 88, 210 |
1件: KIT |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
105 | Melanoma 3 genes, 3 drugs (DrugBank) and 12 diseases shown |
3件: FGFR1, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
1件: PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
106 | Metabolic pathways 10 genes, 8 drugs (DrugBank) and 57 diseases shown |
1件: ALOX5 |
D00414 |
Zileuton |
3件: 85, 160, 164 |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
2件: IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
2件: NQO1, VKORC1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
D01280 |
D08682 |
1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
D08514 |
1件: RRM1 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
107 | MicroRNAs in cancer 7 genes, 6 drugs (DrugBank) and 42 diseases shown |
2件: ABL1, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: ABL1, PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
3件: FGFR3, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TGFB2 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
108 | Mitophagy - animal 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
109 | Morphine addiction 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: OPRM1 |
D00320 |
Fentanyl |
5件: 46, 70, 85, 215, 231 |
D01399 |
D00843 |
Nalbuphine |
1件: 85 |
D08246 |
110 | mTOR signaling pathway 2 genes, 6 drugs (DrugBank) and 61 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
111 | Natural killer cell mediated cytotoxicity 10 genes, 8 drugs (DrugBank) and 59 diseases shown |
2件: FYN, LCK |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
112 | Necroptosis 5 genes, 6 drugs (DrugBank) and 45 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
113 | Neuroactive ligand-receptor interaction 13 genes, 19 drugs (DrugBank) and 78 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: CYSLTR1 |
D00529 |
Montelukast |
5件: 13, 46, 85, 98, 228 |
D08229 |
D06659 |
Tipelukast |
1件: 85 |
1件: EDNRA |
D07077 |
Ambrisentan |
6件: 51, 84, 85, 86, 88, 211 |
2件: EDNRA, EDNRB |
D01227 |
Bosentan |
10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
5件: 51, 85, 86, 88, 210 |
1件: F2 |
D09707 |
Dabigatran |
2件: 85, 91 |
D06410 |
Thrombomodulin Alfa |
1件: 85 |
1件: NR3C1 |
D00246 |
Budesonide |
10件: 66, 85, 93, 94, 95, 96, 97, 98, 228, 299 |
D00472 |
Prednisolone |
38件: 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
D00980 |
D00981 |
D00982 |
D01239 |
D01998 |
D02156 |
D03301 |
D00473 |
Prednisone |
44件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
3件: OPRD1, OPRK1, OPRM1 |
D00843 |
Nalbuphine |
1件: 85 |
D08246 |
1件: OPRM1 |
D00320 |
Fentanyl |
5件: 46, 70, 85, 215, 231 |
D01399 |
1件: P2RX3 |
D11349 |
Gefapixant |
2件: 85, 226 |
1件: PTGIR |
D02721 |
Iloprost |
4件: 51, 84, 85, 86 |
D06213 |
Treprostinil |
5件: 51, 84, 85, 86, 88 |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
114 | Neurotrophin signaling pathway 1 gene, 2 drugs (DrugBank) and 11 diseases shown |
1件: ABL1 |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
115 | NF-kappa B signaling pathway 4 genes, 6 drugs (DrugBank) and 41 diseases shown |
2件: IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: LCK |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
116 | NOD-like receptor signaling pathway 4 genes, 5 drugs (DrugBank) and 41 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
117 | Non-alcoholic fatty liver disease (NAFLD) 5 genes, 6 drugs (DrugBank) and 42 diseases shown |
4件: IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TGFB1 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
118 | Oocyte meiosis 6 genes, 3 drugs (DrugBank) and 30 diseases shown |
1件: AR |
D08250 |
Nandrolone |
2件: 60, 85 |
D00955 |
Nandrolone decanoate |
2件: 60, 85 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
119 | Osteoclast differentiation 14 genes, 9 drugs (DrugBank) and 60 diseases shown |
2件: FYN, LCK |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
2件: TGFB1, TGFB2 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
120 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: ALOX5 |
D00414 |
Zileuton |
3件: 85, 160, 164 |
121 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank) and 15 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
122 | Oxytocin signaling pathway 6 genes, 2 drugs (DrugBank) and 30 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
123 | p53 signaling pathway 1 gene, 1 drug (DrugBank) and 8 diseases shown |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
124 | Pancreatic cancer 5 genes, 3 drugs (DrugBank) and 39 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
125 | Parathyroid hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: FGFR1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
126 | Pathogenic Escherichia coli infection 15 genes, 10 drugs (DrugBank) and 46 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: ABL1, FYN |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: F2 |
D09707 |
Dabigatran |
2件: 85, 91 |
D06410 |
Thrombomodulin Alfa |
1件: 85 |
3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00491 |
Paclitaxel |
2件: 46, 85 |
D05333 |
127 | Pathways in cancer 25 genes, 22 drugs (DrugBank) and 71 diseases shown |
3件: ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
3件: ABL1, KIT, PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: AR |
D08250 |
Nandrolone |
2件: 60, 85 |
D00955 |
Nandrolone decanoate |
2件: 60, 85 |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
1件: EDNRA |
D07077 |
Ambrisentan |
6件: 51, 84, 85, 86, 88, 211 |
2件: EDNRA, EDNRB |
D01227 |
Bosentan |
10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
5件: 51, 85, 86, 88, 210 |
1件: F2 |
D09707 |
Dabigatran |
2件: 85, 91 |
D06410 |
Thrombomodulin Alfa |
1件: 85 |
6件: FGFR1, FGFR2, FGFR3, FLT4, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: IL13 |
D09633 |
Lebrikizumab |
1件: 85 |
D09979 |
Tralokinumab |
2件: 85, 97 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
D01280 |
D08682 |
1件: SMO |
D09992 |
Vismodegib |
1件: 85 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
128 | PD-L1 expression and PD-1 checkpoint pathway in cancer 10 genes, 5 drugs (DrugBank) and 52 diseases shown |
1件: CD274 |
D10773 |
Atezolizumab |
1件: 85 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: LCK |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
129 | Pertussis 5 genes, 5 drugs (DrugBank) and 41 diseases shown |
5件: IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
130 | Phagosome 9 genes, 1 drug (DrugBank) and 2 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00491 |
Paclitaxel |
2件: 46, 85 |
D05333 |
131 | Phospholipase D signaling pathway 7 genes, 7 drugs (DrugBank) and 50 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: F2 |
D09707 |
Dabigatran |
2件: 85, 91 |
D06410 |
Thrombomodulin Alfa |
1件: 85 |
3件: FYN, KIT, PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
2件: KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
132 | PI3K-Akt signaling pathway 14 genes, 8 drugs (DrugBank) and 55 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
3件: EPHA2, KIT, PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
2件: KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
133 | Platelet activation 4 genes, 5 drugs (DrugBank) and 6 diseases shown |
1件: F2 |
D09707 |
Dabigatran |
2件: 85, 91 |
D06410 |
Thrombomodulin Alfa |
1件: 85 |
2件: FYN, SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: PTGIR |
D02721 |
Iloprost |
4件: 51, 84, 85, 86 |
D06213 |
Treprostinil |
5件: 51, 84, 85, 86, 88 |
134 | Platinum drug resistance 2 genes, 1 drug (DrugBank) and 11 diseases shown |
2件: TOP2A, TOP2B |
D00125 |
Etoposide |
11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 |
D04107 |
135 | Primary immunodeficiency 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: LCK |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
136 | Prion diseases 4 genes, 3 drugs (DrugBank) and 13 diseases shown |
1件: FYN |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
3件: IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
137 | Prolactin signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
138 | Prostate cancer 6 genes, 6 drugs (DrugBank) and 40 diseases shown |
1件: AR |
D08250 |
Nandrolone |
2件: 60, 85 |
D00955 |
Nandrolone decanoate |
2件: 60, 85 |
4件: FGFR1, FGFR2, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
1件: PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
139 | Proteoglycans in cancer 9 genes, 11 drugs (DrugBank) and 63 diseases shown |
2件: FGFR1, KDR |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SMO |
D09992 |
Vismodegib |
1件: 85 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
2件: TGFB1, TGFB2 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
140 | Purine metabolism 5 genes, 5 drugs (DrugBank) and 49 diseases shown |
2件: IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
D08514 |
1件: RRM1 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
141 | Pyrimidine metabolism 2 genes, 2 drugs (DrugBank) and 21 diseases shown |
1件: RRM1 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
1件: RRM2 |
D00341 |
Hydroxyurea |
8件: 3, 13, 19, 20, 65, 85, 86, 284 |
142 | Rap1 signaling pathway 12 genes, 4 drugs (DrugBank) and 15 diseases shown |
4件: EPHA2, KIT, PDGFRB, SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
2件: KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
143 | Ras signaling pathway 12 genes, 4 drugs (DrugBank) and 15 diseases shown |
4件: ABL1, EPHA2, KIT, PDGFRB |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
3件: ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
144 | Regulation of actin cytoskeleton 7 genes, 5 drugs (DrugBank) and 13 diseases shown |
1件: F2 |
D09707 |
Dabigatran |
2件: 85, 91 |
D06410 |
Thrombomodulin Alfa |
1件: 85 |
5件: FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: PDGFRB, SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
145 | Regulation of lipolysis in adipocytes 1 gene, 2 drugs (DrugBank) and 14 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
146 | Relaxin signaling pathway 4 genes, 5 drugs (DrugBank) and 18 diseases shown |
1件: EDNRB |
D01227 |
Bosentan |
10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
5件: 51, 85, 86, 88, 210 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: TGFB1 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
147 | Renal cell carcinoma 4 genes, 2 drugs (DrugBank) and 12 diseases shown |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
148 | Renin secretion 8 genes, 7 drugs (DrugBank) and 50 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: EDNRA |
D07077 |
Ambrisentan |
6件: 51, 84, 85, 86, 88, 211 |
D01227 |
Bosentan |
10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
5件: 51, 85, 86, 88, 210 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
149 | Renin-angiotensin system 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
150 | Rheumatoid arthritis 10 genes, 8 drugs (DrugBank) and 46 diseases shown |
5件: CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: FLT1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
151 | RIG-I-like receptor signaling pathway 1 gene, 5 drugs (DrugBank) and 41 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
152 | Salivary secretion 1 gene, 2 drugs (DrugBank) and 14 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
153 | Salmonella infection 5 genes, 3 drugs (DrugBank) and 18 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
3件: IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
154 | Serotonergic synapse 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: ALOX5 |
D00414 |
Zileuton |
3件: 85, 160, 164 |
155 | Shigellosis 5 genes, 8 drugs (DrugBank) and 62 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: ABL1, SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
2件: IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
156 | Signaling pathways regulating pluripotency of stem cells 3 genes, 1 drug (DrugBank) and 4 diseases shown |
3件: FGFR1, FGFR2, FGFR3 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
157 | Sphingolipid signaling pathway 3 genes, 7 drugs (DrugBank) and 41 diseases shown |
1件: FYN |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: OPRD1 |
D00843 |
Nalbuphine |
1件: 85 |
D08246 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
158 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: IL10 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
159 | Systemic lupus erythematosus 3 genes, 6 drugs (DrugBank) and 42 diseases shown |
1件: ELANE |
D03788 |
Sivelestat |
3件: 13, 85, 96 |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
160 | T cell receptor signaling pathway 9 genes, 7 drugs (DrugBank) and 56 diseases shown |
2件: FYN, LCK |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
161 | Taste transduction 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: P2RX3 |
D11349 |
Gefapixant |
2件: 85, 226 |
162 | TGF-beta signaling pathway 4 genes, 6 drugs (DrugBank) and 42 diseases shown |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
163 | Th1 and Th2 cell differentiation 9 genes, 5 drugs (DrugBank) and 33 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: IL13 |
D09633 |
Lebrikizumab |
1件: 85 |
D09979 |
Tralokinumab |
2件: 85, 97 |
1件: LCK |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
164 | Th17 cell differentiation 12 genes, 7 drugs (DrugBank) and 57 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
2件: IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL6 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: LCK |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TGFB1 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
165 | Thermogenesis 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: FGFR1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
166 | Thyroid hormone signaling pathway 2 genes, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
167 | Tight junction 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
168 | TNF signaling pathway 5 genes, 5 drugs (DrugBank) and 41 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
169 | Toll-like receptor signaling pathway 3 genes, 5 drugs (DrugBank) and 41 diseases shown |
3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
170 | Toxoplasmosis 8 genes, 8 drugs (DrugBank) and 47 diseases shown |
1件: ALOX5 |
D00414 |
Zileuton |
3件: 85, 160, 164 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
171 | Transcriptional misregulation in cancer 3 genes, 4 drugs (DrugBank) and 16 diseases shown |
1件: ELANE |
D03788 |
Sivelestat |
3件: 13, 85, 96 |
1件: FLT1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
172 | Tuberculosis 16 genes, 9 drugs (DrugBank) and 60 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
3件: TGFB1, TGFB2, TGFB3 |
D09620 |
Fresolimumab |
4件: 51, 85, 222, 274 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
173 | Type I diabetes mellitus 4 genes, 5 drugs (DrugBank) and 41 diseases shown |
3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
174 | Type II diabetes mellitus 2 genes, 6 drugs (DrugBank) and 61 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
175 | Ubiquinone and other terpenoid-quinone biosynthesis 2 genes, 1 drug (DrugBank) and 10 diseases shown |
2件: NQO1, VKORC1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
D01280 |
D08682 |
176 | Vascular smooth muscle contraction 3 genes, 6 drugs (DrugBank) and 26 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
1件: EDNRA |
D07077 |
Ambrisentan |
6件: 51, 84, 85, 86, 88, 211 |
D01227 |
Bosentan |
10件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
D07538 |
D10135 |
Macitentan |
5件: 51, 85, 86, 88, 210 |
1件: PTGIR |
D02721 |
Iloprost |
4件: 51, 84, 85, 86 |
D06213 |
Treprostinil |
5件: 51, 84, 85, 86, 88 |
177 | VEGF signaling pathway 8 genes, 4 drugs (DrugBank) and 36 diseases shown |
1件: KDR |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: VEGFA |
D06409 |
Bevacizumab |
9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 |
178 | Viral carcinogenesis 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
179 | Viral myocarditis 2 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
D08066 |
2件: ABL1, FYN |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
180 | Viral protein interaction with cytokine and cytokine receptor 5 genes, 5 drugs (DrugBank) and 41 diseases shown |
4件: CCL2, IL10, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
181 | Wnt signaling pathway 5 genes, 1 drug (DrugBank) and 30 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
182 | Yersinia infection 7 genes, 6 drugs (DrugBank) and 41 diseases shown |
5件: CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IL6, TNF |
D08976 |
Pomalidomide |
6件: 28, 34, 51, 85, 227, 331 |
2件: LCK, SRC |
D03658 |
Dasatinib |
1件: 85 |
D06414 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |